InjectionAntacid Anti-Ulcerent

Ranitidine Injection

Ranitidine Hydrochloride · H2 receptor antagonist

InjectionAntacid Anti-Ulcerent

Ranitidine InjectionProspero Healthcare

Ranitidine injection contains an H2 receptor antagonist that reduces gastric acid secretion, for intravenous or intramuscular use. It is used for acid-related conditions when oral therapy is not possible.

Uses

Peptic ulcer
Gastro-oesophageal reflux disease when oral therapy is not possible

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Ranitidine Hydrochloride
Available strengthsIndicative: 25 mg/ml · 50 mg/2 ml
Dosage form: Injection
Therapeutic category: Antacid Anti-Ulcerent Critical Care Injection Infusion
Therapeutic class: H2 receptor antagonist
Packing: Vial or ampoule, single unit or tray pack
Storage: Store below 25 °C, protected from light. Do not freeze.

02Related

From the same category

View the category